Royal Treasure Securities is pleased to announce its successful role as a selling group member in the initial public offering (IPO) of Basel Medical Group Ltd (BMGL). The offer comprised 2,205,000 units of the Company, priced at $4.00 per unit.
Basel Medical Group Ltd (BMGL) aims to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including general and subspecialized orthopedic and trauma services, sports medicine and surgery, neurosurgical treatments, and post-surgery rehabilitation services such as physiotherapy and pain management. They operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical, comprising four orthopedic specialists and one neurosurgery specialist.
The services provided by their clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and their clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities.
Basel Medical Group Ltd began trading on the Nasdaq under the ticker symbol “BMGL” on February 25, 2025. Cathay Securities, Inc served as the sole book-running manager for the offering.